Your browser doesn't support javascript.
loading
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishida, Hisashi; Arakawa, Yuki; Hasegawa, Daiichiro; Usami, Ikuya; Hashii, Yoshiko; Arai, Yasuyuki; Nishiwaki, Satoshi; Keino, Dai; Kato, Keisuke; Sato, Maho; Yoshida, Nao; Ozawa, Yukiyasu; Okada, Keiko; Hidaka, Moe; Yuza, Yuki; Tanaka, Masatsugu; Watanabe, Kenichiro; Takita, Junko; Kosaka, Yoshiyuki; Fujita, Naoto; Tanaka, Junji; Sato, Atsushi; Atsuta, Yoshiko; Imamura, Toshihiko.
Afiliación
  • Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
  • Arakawa Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Hasegawa D; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Usami I; Department of Pediatric Hematology and Oncology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
  • Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan.
  • Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nishiwaki S; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Keino D; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kato K; Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Ibaraki, Japan.
  • Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan.
  • Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
  • Okada K; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
  • Hidaka M; Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
  • Yuza Y; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Watanabe K; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Takita J; Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan.
  • Kosaka Y; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Fujita N; Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
  • Imamura T; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Ann Hematol ; 103(3): 843-854, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38006571

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adolescent / Child / Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adolescent / Child / Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania